Background: Population mean changes are difficult to use in clinical practice. Responder analysis may be better, but needs validating for level of response and treatment duration. A consensus group ...
October 8, 2012 (Berlin, Germany) — The largest trial ever conducted for the treatment of diabetic peripheral neuropathic pain (DPNP) shows that combination therapy with duloxetine (Cymbalta, Eli ...
Review of 2 pivotal phase 3 trials that evaluated the efficacy and safety of pregabalin for the management of FM. Results: FM is a chronic condition that is characterized by widespread musculoskeletal ...
The randomized, double-blind, 12-month trial, A0081186, was conducted with more than 700 patients. Patients participating in the study were randomized to receive either a placebo, Lyrica (300 mg/day, ...
Pregabalin is a prescription drug. It comes in three forms: a capsule, a solution, and an extended-release tablet. All forms are taken by mouth. Pregabalin oral capsule is available as the brand-name ...
Pregabalin, known to many by its trade name, “Lyrica,” works well, when, well, it works. A recent review of clinical studies involving Lyrica for the treatment of fibromyalgia concluded that only a ...
India plans to place pregabalin under Schedule H1 to curb misuse. The move would mandate prescription-only sales, strict record-keeping, and tighter oversight while ensuring access for genuine ...
Chinese adults with diabetic neuropathy assigned the anticonvulsant medication pregabalin did not see an improvement in mean pain score compared with those assigned a placebo, according to findings ...
The government is looking to control the sale of Pregabalin. This common medicine is being misused. The government wants to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results